These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20550515)

  • 21. [Prostaglandins and their effect on the skin].
    Mordovtsev VN; Samsonov VA; Zavadskaia IuN
    Sov Med; 1975 Jun; (6):74-7. PubMed ID: 169597
    [No Abstract]   [Full Text] [Related]  

  • 22. Potassium iodide in dermatology.
    Hassan I; Keen A
    Indian J Dermatol Venereol Leprol; 2012; 78(3):390-3. PubMed ID: 22565452
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic action of a new non-steroid drug (bufexamac) in the treatment of inflammatory dermatologic diseases. Double-blind clinical study].
    Katsambas A; Vareltzidis A
    Brux Med; 1973 Aug; 53(8):463-8. PubMed ID: 4751895
    [No Abstract]   [Full Text] [Related]  

  • 24. [3M Cavilon--a non-irritating dermatologic agent].
    Wangen S
    Krankenpfl J; 2000 Dec; 38(11-12):395. PubMed ID: 11272990
    [No Abstract]   [Full Text] [Related]  

  • 25. Cosmeceuticals and natural products: wound healing.
    Davis SC; Perez R
    Clin Dermatol; 2009; 27(5):502-6. PubMed ID: 19695483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The return of investment of translational research in inflammatory dermatoses.
    van de Kerkhof PC
    J Dermatolog Treat; 2008; 19(6):317. PubMed ID: 18982511
    [No Abstract]   [Full Text] [Related]  

  • 27. Dermatologic therapy: December, 1979, through November, 1980.
    Coskey RJ
    J Am Acad Dermatol; 1981 Jul; 5(1):67-87. PubMed ID: 6456281
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils.
    Lin TK; Zhong L; Santiago JL
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29280987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sure and riskless treatment of dermatoses with a new skin medication].
    Kumpmann U
    Med Welt; 1969 Nov; 48():2652-4. PubMed ID: 4247879
    [No Abstract]   [Full Text] [Related]  

  • 30. [Principles of treatment and protection for sensitive skin].
    Kerscher M
    Hautarzt; 2011 Dec; 62(12):906-13. PubMed ID: 22160226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of Kenacort-A-tincture in dermatologic disorders].
    Kroepfli P
    Schweiz Rundsch Med Prax; 1972 Apr; 61(16):532-5. PubMed ID: 5021823
    [No Abstract]   [Full Text] [Related]  

  • 32. The artful use of topical steroids.
    Brodkin RH; Janniger CK
    Cutis; 1998 Mar; 61(3):125-6. PubMed ID: 9538949
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prescription Tip: old and new].
    Wolf G; Gehring W
    Hautarzt; 2009 Jun; 60(6):450-1. PubMed ID: 19543866
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dermatologic experiences with a new ointment foundation with the saturated fatty acid glyceride base].
    Schrümpf E
    Wien Med Wochenschr; 1968 Jan; 118(3):47-52. PubMed ID: 4233268
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of MAS063DP lotion vs 0.02% triamcinolone acetonide lotion in improving post-ablative fractional CO
    Lueangarun S; Tempark T
    Int J Dermatol; 2018 Apr; 57(4):480-487. PubMed ID: 29431228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bufexamac: a review of its pharmacological properties and therapeutic efficacy in inflammatory dermatoses.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1975; 10(5-6):351-6. PubMed ID: 1204506
    [No Abstract]   [Full Text] [Related]  

  • 37. [Not Available].
    CEDEF
    Ann Dermatol Venereol; 2018 Mar; 145 Suppl 1():S201-S204. PubMed ID: 29471974
    [No Abstract]   [Full Text] [Related]  

  • 38. Oatmeal in dermatology: a brief review.
    Pazyar N; Yaghoobi R; Kazerouni A; Feily A
    Indian J Dermatol Venereol Leprol; 2012; 78(2):142-5. PubMed ID: 22421643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapies in cutaneous pathologies: an overview.
    Baylet A; Laclaverie M; Marchand L; Bordes S; Closs-Gonthier B; Delpy L
    Drug Discov Today; 2021 Jan; 26(1):248-255. PubMed ID: 33137480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The dermocorticoids, irreplaceable and feared].
    Zenklusen C; Feldmeyer L
    Rev Med Suisse; 2014 Apr; 10(425):821-6. PubMed ID: 24791429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.